The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies

The safety and tolerability of vortioxetine in adults with major depressive disorder was assessed. Tolerability was based on the nature, incidence and severity of treatment-emergent adverse events (TEAEs) during acute (6/8) week treatment in 11 randomized, double-blind placebo-controlled short-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldwin, David S, Chrones, Lambros, Florea, Ioana, Nielsen, Rebecca, Nomikos, George G, Palo, William, Reines, Elin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794082/
https://www.ncbi.nlm.nih.gov/pubmed/26864543
http://dx.doi.org/10.1177/0269881116628440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794082/
https://www.ncbi.nlm.nih.gov/pubmed/26864543
http://dx.doi.org/10.1177/0269881116628440

Ejemplares similares